CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON
Technology
E-050-2014
Patent ID
E-050-2014-0-US-02
Country
US
Application Type
DIV
Patent Status
Pending
Patent Number
Publication Number
US-2023-0257775-A1
Application Number
18/174,013
IC
NCI
Date Filed
Date Issued
Patent PDF